India has approved the Oxford/AstraZeneca vaccine for emergency use which will begin a tireless immunisation campaign as the country hopes to inoculate 300 million people before August 2021.

The Oxford/AstraZeneca vaccine was given emergency approval on Saturday in a bid to stem the tide of the virus in the second-worst hit nation in the world.

India has more than 10 million total coronavirus cases, which is only second to the United States' which has recorded just under 21 million infections.

The world's second most populated nation is also recording more than 15,000 deaths every single day.

свернуть